Meningococcal

Meningococcal disease is rare but can progress rapidly, especially in children, teens, and travellers. It spreads through respiratory droplets, such as coughing or close contact with an infected person. The infection can cause brain damage, hearing loss, or death if left untreated. Vaccination is the most effective and evidence-based protection against this fast-moving illness. The Meningococcal Vaccine (MenACWY) provides broad, long-lasting defence against four major strains A, C, W, and Y, helping protect both individuals and communities.

It helps prevent meningitis (brain and spinal cord inflammation), septicaemia (blood infection), and long-term complications such as neurological damage and hearing loss. The vaccine protects against Neisseria meningitidis, the bacterium responsible for most meningococcal infections worldwide.

• Provides long-term protection against four major meningococcal strains (A, C, W, Y)
• Reduces risk of severe brain and blood infections
• Recommended for travellers, students, and those in crowded settings
• Helps build community immunity and lowers outbreak risk
• Prevents life-threatening complications across age groups

Most side effects are mild and short-lived:

The safety precautions patients need to follow before receiving the meningococcal vaccine:

• Inform your doctor about any allergies or prior vaccine reactions
• Postpone vaccination in case of severe illness or high fever
• Mild colds or minor illnesses usually don’t delay vaccination
• Have a light meal and stay well hydrated before your appointment
• Remain under observation for about 15 minutes afterwards